Press release
Alcoholic Hepatitis Therapeutics Market Research Report by Regional Analysis - North America, Europe, Asia Pacific, Latin America, Middle East & Africa : forecast 2024
Alcoholic Hepatitis Therapeutics Market: OverviewAlcoholic hepatitis is a kind of liver disease usually characterized by progressive inflammation of the liver due to long-term heavy intake of alcohol. Alcoholic hepatitis is generally associated with hepatosteatosis (an early stage of alcoholic liver disorder) that might lead to liver cirrhosis. The pathogenesis of the disease is not completely understood. Severely affected patients usually show symptoms such as ascites, fatigue, jaundice, hepatomegaly, hepatic encephalopathy and fever, amongst others. Currently, the alcoholic hepatitis therapeutics market is a lucrative market venture due to high patient preference and the increasing base of patients with liver diseases, which makes this industry a highly profitable and attractive market.
Alcoholic Hepatitis Therapeutics Market: Segmentation
Some of the currently available therapeutic products that are being used for the treatment of alcoholic hepatitis are as follows:
Monoclonal antibodies
Remicade
Caspase protease inhibitor
Emricasan
Corticosteroids
Medrol
Hemorheologic agents
Trental
Anabolic steroids
Oxandrolone
Thiocarbamide compounds
Hepatotropic hormones
Sulfhydryl agents
Herbal agents
Some of the pipeline therapeutics that are being developed for the treatment of alcoholic hepatitis and other liver diseases are as follows:
ALF-5755
INT-747
IMM-124E
F-652
GRI-0621
Browse full report on Alcoholic Hepatitis Therapeutics Market -
http://www.transparencymarketresearch.com/alcoholic-hepatitis-therapeutics-market.html
Alcoholic Hepatitis Therapeutics Market: Geographical Dynamics
In terms of geography, North America is the largest market for alcoholic hepatitis therapeutics owing to the high incidence of alcoholic liver diseases. Various studies suggest that more than 2 million people in the U.S. suffer from an alcoholic liver disease. However, the actual prevalence of alcoholic hepatitis is still unknown due to the asymptomatic nature of the disease and ignorance among patients for seeking medical attention. The prevalence of alcoholic hepatitis widely differs among different countries and races globally. In the Western Hemisphere, the prevalence of alcoholic hepatitis was found to be approximately 25% to 30%. However, other regions such as South East Asia, Latin America and the Middle East are expected to be the potential markets in the near future. Owing to the rising disposable income among the population and high adoption rate for novel therapeutics for liver diseases, these regions are expected to be the potential market in near future.
Alcoholic Hepatitis Therapeutics Market: Drivers and Restraints
The overall alcoholic hepatitis therapeutics market is expected to witness remarkable growth due to the increasing incidence of liver diseases and high success rate of pipeline drugs. Moreover, increasing prevalence of alcoholic liver diseases and high adoption rate for novel therapeutic products are some of the factors that are expected to fuel the demand for alcoholic hepatitis therapeutics globally. It has also been estimated that the global alcoholic hepatitis therapeutics market shows potential to be a lucrative and expanding field due to increasing mergers and acquisitions among existing and emerging pharmaceuticals companies to develop novel therapies for treating liver diseases. Additionally, expected technological breakthroughs will generate abundant opportunities for detecting liver diseases and monitoring disease progression. Furthermore, increased focus on retaining superior quality of life is one of the factors contributing to the growth of this market. However, escalating healthcare expenditure, stringent reimbursement policies and high development costs are some of the market-restraining factors that might hinder the growth of the alcoholic hepatitis therapeutics market in future.
Alcoholic Hepatitis Therapeutics Market: Key Players
Some of the major players involved with the development of alcoholic hepatitis therapeutics are Alkermes, Inc., Alfact Innovation, Conatus Pharmaceuticals, Inc., Dainippon Sumitomo Pharma Co., Ltd., Galectin Therapeutics, Generon (Shanghai) Corporation Ltd., Immuron Limited, Intercept Pharmaceuticals, Inc., Lupin Laboratories Ltd., Sanofi-Aventis, Siesta Pharmaceuticals and Teva Pharmaceutical Industries Ltd.
Request for brochure of this report -
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=12209
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Alcoholic Hepatitis Therapeutics Market Research Report by Regional Analysis - North America, Europe, Asia Pacific, Latin America, Middle East & Africa : forecast 2024 here
News-ID: 447838 • Views: …
More Releases from Transparency Market Research - Pharmaceutical

Neurovascular Devices Market Business Opportunities and Growth Challenges Report
Global Neurovascular Devices Market: Overview
The global population is aging rapidly. According to WHO, the chances of health risks are greater in geriatric people than the young generation. Old age is considered to be one of the biggest risk factors that are responsible for developing various diseases such as cardiovascular and neurological conditions. It is because of these factors, the global neurovascular devices market is experiencing robust growth in the…

Pneumococcal Vaccines Market anticipated expand at a CAGR of 3.3% from 2018 to 2 …
Transparency Market Research (TMR) has published a new report titled, “Pneumococcal Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the report, the global pneumococcal vaccines market was valued at US$ 7,247.6 Mn in 2017 and is anticipated expand at a CAGR of 3.3% from 2018 to 2026. Increase in patient pool, growth of the pharmaceutical industry, government initiatives to increase vaccination programs, rise…

Swab and Viral Transport Medium Market projected to expand at a CAGR of ~3% from …
Swab and Viral Transport Medium Market:
Introduction
Transparency Market Research has published a new report titled, ‘Global Swab and Viral Transport Medium Market ’. According to the report, the global swab and viral transport medium market was valued at US$ 0.9 Bn in 2019 and is projected to expand at a CAGR of ~3% from 2020 to 2030. Viral transport medium (VTM) enables safe transfer of viruses, chlamydia, and mycoplasma for…
Radiofrequency Ablation Devices Market by Product, Geography and Forecast to 202 …
Transparency Market Research (TMR) has published a new report titled, 'Radiofrequency Ablation Devices for Pain Management Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019-2027'. According to the report, the global radiofrequency ablation devices for pain management market was valued at US$ 543.0 Mn in 2018 and is projected to expand at a CAGR of above 11.0% from 2019 to 2027.
Overview
Radiofrequency ablation is a minimally invasive surgical…
More Releases for Alcoholic
Alcoholic Energy Drinks Market Growing Trend of Caffeinated Alcoholic Beverages
On April 02, 2025, Exactitude Consultancy., Ltd. announces the release of the report "Global Alcoholic Energy Drinks Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2034". The report is a detailed and comprehensive analysis presented by region and country, type and application. As the market is constantly changing, the report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands…
Alcoholic Beverage Packaging Market Report 2024 - Alcoholic Beverage Packaging M …
"The Business Research Company recently released a comprehensive report on the Global Alcoholic Beverage Packaging Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, The alcoholic beverage…
Alcoholic and Non Alcoholic Beverages Market Size 2024 to 2031.
Market Overview and Report Coverage
The Alcoholic and Non Alcoholic Beverages Market encompasses a wide range of drinks including beer, wine, spirits, soft drinks, and more. The market has been witnessing steady growth and is expected to continue its upward trajectory in the coming years. With changing consumer preferences, rising disposable incomes, and increasing demand for premium and innovative beverages, the market is poised for further expansion.
In terms of…
Alcoholic and Non-Alcoholic Beverages Market to Show Incredible Growth by 2027 C …
This Alcoholic and Non-Alcoholic Beverages market research performs systematic analysis of the market to provide profound perceptions, determine market situation and potent advancements and track prior market performances. There were several industries got shutdown due to the COVID-19 plague. This market report captures the considerable losses that businesses got and even guides them how to come out of this pandemic situation. As this pandemic left several adverse effects on different…
Alcoholic and Non-Alcoholic Beverages Market Research
This report studies the global Alcoholic and Non-Alcoholic Beverages market status and forecast, categorizes the global Alcoholic and Non-Alcoholic Beverages market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia).
Download FREE Sample of this Report @ https://www.grandresearchstore.com/report-sample/global-alcoholic-nonalcoholic-beverages-2018-575
The major manufacturers covered in this report
Anheuser-Busch
Accolade Wines
Bacardi
Beam Suntory
Carlsberg
Constellation Brands
China Resource Enterprise
Diageo
Heineken
E. & J.…
Non-alcoholic Malt Beverages Posing a Healthy Alternative to Alcoholic Drinks Pr …
Future Market Insights (FMI) delivers key insights on the global non-alcoholic malt beverages market in its upcoming outlook titled 'Global Market Study on Non-alcoholic Malt Beverages: Pairing Options with the Flavors of Non-alcoholic Malt Beverages Likely to Please the Food Palates of Consumers'. In terms of value, the global non-alcoholic malt beverages market is projected to register a healthy CAGR of 4.0% during the forecast period, due to various factors,…